Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-855-1 | CAS number: 75-26-3
Endpoint summary
Administrative data
Description of key information
The key repeated dose oral toxicity study (HSDB 2002 citing Jeong 2002), which was not conducted in accordance with the applicable OECD Guideline or GLP, showed immunitoxicity to cells in the male rat spleen and thymus at 1,000 mg/kg bw/day (LOAEL) 2-bromopropane ingested daily for 28 consecutive days. No adverse effects were observed at 330 mg/kg bw/day (NOAEL) during the same exposure period.
The key repeated dose inhalation toxicity study (JBRC 1999), which was conducted according to OECD 422 and to GLP, showed decreases in male testis weight in the rat following 6-hour daily exposure to 2-bromopropane for 14 consecutive days at a vapour concentration of 1,000 ppm (LOAEC). No adverse effects were observed at 500 ppm (NOAEC) during the same exposure period.
Supporting documentation from genetic toxicity and toxicity to reproduction studies indicated that repeated exposure to 2-bromopropane resulted in adverse effects.
Key value for chemical safety assessment
Additional information
For repeated dose oral and inhalation toxicity, the most recent reliable study was selected as the key study.
Justification for classification or non-classification
Based upon the available studies for repeated exposures via ingestion and inhalation, 2-bromopropane does not require classification as STOT-RE Category 1 or 2 as described in EC No 1272/2008, because the LOAEL and LOAEC determined in the key studies were higher than the guideline value ranges. Labeling as R48/20 (Harmful: Danger of Serious Damage to Health by Prolonged Exposure Through Inhalation) is appropriate based upon the body of evidence.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
